Results 111 to 120 of about 10,149 (228)

Additive Manufacturing of NiTi Shape Memory Alloys for Elastocaloric Applications: A Review

Advanced Functional Materials, Volume 36, Issue 46, 8 June 2026.
Additive manufacturing enables complex NiTi architectures that overcome key limitations in elastocaloric refrigeration, including poor heat transfer and high mechanical work input. This review surveys recent advances in LPBF‐ and DED‐fabricated NiTi shape memory alloys for elastocaloric applications, highlighting process–structure–performance ...
Ignatius Andre Setiawan, Mohammad Mehrali, Jaka Tušek, Shiva Mohajerani, Xiebin Wang, Dermot Brabazon, Mohammad Elahinia, Mehrshad Mehrpouya   +7 more
wiley   +1 more source

Dental, skeletal and soft tissue changes after bimaxillary protrusion treatment with temporary anchorage devices using different retraction mechanics

BMC Oral Health
Background Temporary anchorage devices (TADs), which are absolute anchorage, are used for retraction of the anterior teeth in cases of severe bimaxillary protrusion.
Kotoe Mayahara, Satoru Kawai, Tomihiro Fujisaki, Noriyoshi Shimizu   +3 more
doaj   +1 more source

The TAD World!

APOS Trends in Orthodontics, 2017
Nikhilesh Vaid, Doshi Viraj
openaire   +1 more source

Population pharmacokinetics and dose–response relationships of mitoxantrone in children with acute myeloid leukaemia

British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1760-1770, June 2026.
Background Information on mitoxantrone pharmacokinetics in children is lacking and reduced dosing regimens applied to infants are supported by limited scientific rationale. The current study characterized mitoxantrone pharmacokinetics in a childhood acute myeloid leukaemia patient population and provides a data‐informed assessment of dosing.
Andrew M. Brandon, Hinke Huisman‐Siebinga, Shelby Barnett, Paul Wetherell, Pamela Kearns, Brenda Gibson, Nicholas Heaney, Owen Smith, André Baruchel, Arnaud Petit, Andrew Moore, Kayode Ogungbenro, Alwin D. R. Huitema, Gareth J. Veal   +13 more
wiley   +1 more source

Genetic and Clinical Features in TP53‐Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next‐Generation Sequencing Data

Cancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background The recent fifth edition of World Health Organization and International Consensus Classification in 2022 recognized TP53‐mutated myelodysplastic neoplasms (MDS) as a distinct entity requiring multi‐hit classification. Literatures indicate that TP53 variant alle frequency (VAF) correlates with clinical outcomes.
Yanming Cheng, Lixia Liu, Yu Gao, Yifei Wang, Wei Zhu, Hong Chen, Jiayue Qin, Yudi Zhang   +7 more
wiley   +1 more source

TAD Regimen [PDF]

, 2020
openaire   +1 more source

The Effects of Inspiratory Muscle Training on Diaphragm Thickness, Respiratory Muscle Strength, Balance, and Core Stability in Professional Dancers: A Randomized Controlled Trial

European Journal of Sport Science, Volume 26, Issue 6, June 2026.
ABSTRACT This study aimed to investigate the effects of progressive resistance IMT on diaphragm muscle thickness, inspiratory muscle strength, balance, and isometric endurance of the hip‐back extensor muscles in professional dancers. Thirty‐six professional dancers (15 male, 21 female) aged 16–47 years were randomly assigned to either a training group (
Hakan Aksu, Sergen Devran, Suat Morkuzu, Bülent Bayraktar   +3 more
wiley   +1 more source

Cytogenetic and Molecular Analysis of a “Double‐Hit” RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia

Genes, Chromosomes and Cancer, Volume 65, Issue 6, June 2026.
ABSTRACT Introduction Alterations involving RUNX1 are recurrent in hematologic malignancies and contribute to disease pathogenesis via dysregulation of transcriptional factors essential for hematopoiesis. Here, we report an acquired alteration in both alleles of RUNX1; one is a truncating mutation and the second is a novel RUNX1::ARID1B identified in ...
Rolando García, Jing Xu, Lan Yu, Kalayarasan Srinivasan, Sharon Koorse Germans, Olga Weinberg, Franklin Fuda, Weina Chen, Prasad Koduru   +8 more
wiley   +1 more source

Biological Drivers of IMiD‐Induced Peripheral Neuropathy in Multiple Myeloma

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT The introduction of immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, have led to significant improvements in multiple myeloma (MM) treatment. Many patients now live 10 years or longer with their disease, making treatment‐related side effects increasingly important.
Sina A. Beer, Richard Houlston, Martin F. Kaiser   +2 more
wiley   +1 more source

The TAD-pathway for GWAS signals [PDF]

European Journal of Human Genetics, 2017
Prokopenko, I, Pervjakova, N
openaire   +4 more sources